CRIS
Curis Inc
NASDAQ: CRIS · HEALTHCARE · BIOTECHNOLOGY
$0.57
-3.33% today
Updated 2026-11-12
Market cap
$1.46M
P/E ratio
0.46
P/S ratio
0.34x
EPS (TTM)
$1.32
Dividend yield
—
52W range
$0 – $30
Volume
5.0M
Curis Inc (CRIS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.57
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$5.44
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.46x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.